 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Directors of Venus Remedies Ltd at its meeting held on June 24, 2016, has considered that in the light of the delay in some pending permissions, the Board has decided to withdraw the proposal of Preferential Allotment of 9,00,000 equity shares of Rs. 10/- each approved at AGM held on August 25, 2015 with liberty to consider a fresh proposal of allotment of shares at an appropriate stage by placing the same before the general meeting.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.76.05 as compared to the previous close of Rs. 79.35. The total number of shares traded during the day was 9776 in over 200 trades.
The stock hit an intraday high of Rs. 77.7 and intraday low of 72.8. The net turnover during the day was Rs. 736392.